Cogent Biosciences Inc (COGT)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -48.148 | -41.001 | -51.166 | -47.038 | -49.816 | -29.926 | -52.633 | -62.649 |
Return on Equity (%) | 147.283 | 69.501 | -606.744 | -69.205 | -56.156 | -32.204 | -59.687 | -74.935 |
Return on Invested Capital (%) | 146.958 | 18950.725 | -85.485 | -72.604 | -62.392 | -34.139 | -64.251 | -83.844 |
Operating Margin (%) | -285.193 | -304.928 | -354.757 | -141.486 | -950.426 | N/A | N/A | N/A |
Net Profit Margin (%) | -286.2 | -305.706 | -354.921 | -141.486 | -950.426 | N/A | N/A | N/A |
Book Value Per Share | -2.424 | 2.774 | 2.004 | 1.036 | 3.827 | 2.933 | 2.714 | 2.294 |
Earnings Per Share | -1.785 | -2.505 | -1.149 | -1.038 | -2.313 | -1.646 | -2.004 | -2.232 |
Cash Per Share | 4.055 | 2.771 | 1.852 | 1.22 | 7.487 | 5.003 | 1.999 | 0.618 |
Working Capital Per Share | 5.986 | 3.057 | 1.865 | 0.892 | 7.166 | 4.681 | 3.403 | 2.698 |
Operating Profit Per Share | 0.624 | 0.819 | 0.324 | 0.734 | 0.243 | N/A | N/A | N/A |
EBIT Per Share | -1.779 | -2.499 | -1.149 | -1.038 | -2.313 | -1.646 | -2.004 | -2.232 |
EBITDA Per Share | -1.779 | -2.499 | -1.149 | -1.038 | -2.313 | -1.646 | -2.004 | -2.232 |
Free Cash Flow Per Share | -1.542 | -2.53 | -1.175 | -1.079 | -1.981 | -1.609 | -1.918 | -2.226 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 10,19M | 10,2M | 30,06M | 30,66M | 32,35M | 43,81M | 69,89M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 69,89M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 904,68M |
Ratio cours/bénéfice | -1,35 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 4,88 |
Ratio prix/valeur comptable | 1,01 |
Rendement de dividende | - |
Actions en circulation | 110,46M |
Volume moyen (1 semaine) | 1,9M |
Volume moyen (1 mois) | 1,72M |
Variation sur 52 semaines | 55,28% |
Plus haut sur 52 semaines | 12,61 |
Plus bas sur 52 semaines | 4,28 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales